U.S. officials have authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination.
The Food and Drug Administration granted emergency use Wednesday to the drug combo made by AstraZeneca.
The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations. Health experts estimate about 2% to 3% of the U.S. population falls into that group.
Other antibody drugs are used to treat COVID-19 or prevent infection after possible exposure to the virus. The new AstraZeneca drug is intended for long-term prevention, not a treatment.
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…